Gasdermin D Plays an Oncogenic Role in Glioma and Correlates to an Immunosuppressive Microenvironment
Biomolecules · 2023
DOI: 10.3390/biom13060904 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomolecules, 2023. Verfasst von Mengyuan Li und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Peking University Third Hospital, Beijing 100191, China. Hauptthemen laut MEDLINE: Gasdermins, Glioma, Tumor Microenvironment. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Beijing Municipality, Beijing University Third Hospital.
Abstract (Originalsprache)
Background
Understanding the molecular mechanisms driving oncogenic processes in glioma is important in order to develop efficient treatments. Recent studies have proposed gasdermin D (GSDMD) as a newly discovered pyroptosis executive protein associated with tumorigenesis. However, the precise effect of GSDMD on glioma progression remains unknown.
Methods
The expression levels of GSDMD in 931 glioma and 1157 normal control tissues were collected. A series of bioinformatic approaches and in vivo and in vitro experiments were used to investigate the roles and mechanisms of GDSMD in glioma.
Results
Significant upregulation of GSDMD was detected in glioma tissues compared to normal brain tissues. Patients with glioma and higher GSDMD levels had shorter overall survival, and the Cox regression analysis revealed that GSDMD was an independent risk factor. In addition, upregulation of GSDMD was associated with higher tumor mutation burden and PD-1/PD-L1 expression. Immune infiltration and single-cell analyses indicated that GSDMD was positively associated with an immunosuppressive microenvironment with more infiltrated macrophages and cancer-associated fibroblasts. Furthermore, the in vitro and in vivo experiments revealed that GSDMD knockdown inhibited glioma proliferation, migration, and growth in vivo.
Conclusion
Our analyses revealed a relatively comprehensive understanding of the oncogenic role of GSDMD in glioma. GSDMD is a promising prognostic biomarker and a potential target for glioma treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiation Oncology, Peking University Third Hospital, Beijing 100191, China.
ORCID-Profile: Junjie Wang
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Beijing Municipality
- Beijing University Third Hospital
- Special Fund of the National Clinical Key Specialty Construction Program, P. R. China (2021), the Cancer Precision Radiotherapy Spark Program of China Internat…
Zitieren
APA
Li, M., Jiang, P., Wei, S., Yang, Y., Xiong, L., Wang, J., & Li, C. (2023). Gasdermin D Plays an Oncogenic Role in Glioma and Correlates to an Immunosuppressive Microenvironment. Biomolecules. https://doi.org/10.3390/biom13060904
Vancouver
Li M, Jiang P, Wei S, Yang Y, Xiong L, Wang J, et al. Gasdermin D Plays an Oncogenic Role in Glioma and Correlates to an Immunosuppressive Microenvironment. Biomolecules. 2023. doi:10.3390/biom13060904
BibTeX
@article{Li2023,
author = {Li, Mengyuan and Jiang, Ping and Wei, Shuhua and Yang, Yuhan and Xiong, Liting and Wang, Junjie and Li, Chunxiao},
title = {Gasdermin D Plays an Oncogenic Role in Glioma and Correlates to an Immunosuppressive Microenvironment},
journal = {Biomolecules},
year = {2023},
doi = {10.3390/biom13060904}
}
EUVIMED